Q2 2018

Filed Aug 14, 2018 · 10-Q · 45 days after period end · 0001477932-18-004004

Q2 2018 · 10-Q

Revenue

$98.67K

−53.1% vs Q2 2017

Net Income

-$1.22M

N/M vs Q2 2017

EPS Diluted

$0.00

−100.0% vs Q2 2017

Operating Income-$741,455N/M

Operating Cash Flow

Same quarter

Metric	Q2 2018	Q2 2017	Q2 2016	Q2 2015
Revenue	$98.67K	$210.54K	$187.91K	$457.78K
Net Income	-$1.22M	$11.30M	-$1.07M	-$3.77M
EPS Diluted	$0.00	$0.02	-$0.01	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR